VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 168 filers reported holding HAEMONETICS CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2015$23,402,000
-33.7%
565,825
-28.0%
0.33%
-38.8%
Q1 2015$35,315,000
-46.2%
786,175
-55.2%
0.54%
-43.7%
Q4 2014$65,616,000
+21.8%
1,753,500
+13.7%
0.96%
+18.8%
Q3 2014$53,866,000
+17.0%
1,542,550
+18.2%
0.80%
+23.1%
Q2 2014$46,031,0001,304,7500.65%
Other shareholders
HAEMONETICS CORP shareholders Q3 2014
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders